Amgen Presentations & Investor Relations material

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to and thank you for your assistance.

amgen.com

Amgen presentations

AMGEN Investor Presentation 2020 image

AMGEN Investor Presentation 2020

Amgen logo
Amgen
American Academy of Dermatology Investor Call image

American Academy of Dermatology Investor Call

Amgen logo
Amgen
Q1 16 Earnings Call image

Q1 16 Earnings Call

Amgen logo
Amgen
AMG 160 Data at Esmo Virtual Congress 2020 image

AMG 160 Data at Esmo Virtual Congress 2020

Amgen logo
Amgen
Q117 Earnings Call image

Q117 Earnings Call

Amgen logo
Amgen
AMG 133 Program Update image

AMG 133 Program Update

Amgen logo
Amgen
Q4 ’23 Earnings Call image

Q4 ’23 Earnings Call

Amgen logo
Amgen
Amgen at Asco20 Virtual Scientific Program image

Amgen at Asco20 Virtual Scientific Program

Amgen logo
Amgen
Tezepelumab: a Differentiated, First-in-class Investigational Therapy For a Broad Population With Severe Uncontrolled Asthma image

Tezepelumab: a Differentiated, First-in-class Investigational Therapy For a Broad Population With Severe Uncontrolled Asthma

Amgen logo
Amgen
Amgen Q2 ’15 Earnings Call image

Amgen Q2 ’15 Earnings Call

Amgen logo
Amgen
2021 Annual Meeting of Stockholders image

2021 Annual Meeting of Stockholders

Amgen logo
Amgen
Amgen to Acquire Horizon Therapeutics image

Amgen to Acquire Horizon Therapeutics

Amgen logo
Amgen
Q1 ’15 Earnings Call image

Q1 ’15 Earnings Call

Amgen logo
Amgen
Biosimilars image

Biosimilars

Amgen logo
Amgen
Investor Presentation image

Investor Presentation

Amgen logo
Amgen
Repatha: Steps to Improve Affordability and Access for Patients with Cardiovascular Disease image

Repatha: Steps to Improve Affordability and Access for Patients with Cardiovascular Disease

Amgen logo
Amgen
Amgen Q3 ’15 Earnings Call image

Amgen Q3 ’15 Earnings Call

Amgen logo
Amgen
Amgen Sotorasib Data at Esmo Virtual Congress 2020 image

Amgen Sotorasib Data at Esmo Virtual Congress 2020

Amgen logo
Amgen
AMGEN Q4 ’15 Earnings Call image

AMGEN Q4 ’15 Earnings Call

Amgen logo
Amgen
Q4 ’17 EARNINGS CALL image

Q4 ’17 EARNINGS CALL

Amgen logo
Amgen
Amg 510 Update From Esmo 2019 image

Amg 510 Update From Esmo 2019

Amgen logo
Amgen
Q3 ’16 Earnings Call image

Q3 ’16 Earnings Call

Amgen logo
Amgen
Q2 ’16 Earnings Call image

Q2 ’16 Earnings Call

Amgen logo
Amgen
Amgen Q1 ’23 Earnings Call image

Amgen Q1 ’23 Earnings Call

Amgen logo
Amgen
2014 Business Review image

2014 Business Review

Amgen logo
Amgen
Q4 ’18 Earnings Call image

Q4 ’18 Earnings Call

Amgen logo
Amgen
42 Nd Annual J.P. Morgan Healthcare Conference image

42 Nd Annual J.P. Morgan Healthcare Conference

Amgen logo
Amgen
Amgen Q2 14 Earnings Call image

Amgen Q2 14 Earnings Call

Amgen logo
Amgen
Investor Presentation image

Investor Presentation

Amgen logo
Amgen
Q3 19 Earnings Call image

Q3 19 Earnings Call

Amgen logo
Amgen
Amgen 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE image

Amgen 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Amgen logo
Amgen
Q1 19 Earnings Call image

Q1 19 Earnings Call

Amgen logo
Amgen
36th Annual J.P. Morgan Healthcare Conference image

36th Annual J.P. Morgan Healthcare Conference

Amgen logo
Amgen
KHK4083 Collaboration with Kyowa Kirin Lumakras™ (Sotorasib) Approval image

KHK4083 Collaboration with Kyowa Kirin Lumakras™ (Sotorasib) Approval

Amgen logo
Amgen
Hematology / Oncology Update Esmo 2023 image

Hematology / Oncology Update Esmo 2023

Amgen logo
Amgen
Q1 21 Earnings Call image

Q1 21 Earnings Call

Amgen logo
Amgen